Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-24-024791
Filing Date
2024-06-21
Accepted
2024-06-21 17:14:29
Documents
6

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 364021
2 ex5-1.htm EX-5.1 14851
3 ex23-1.htm EX-23.1 4093
4 ex107.htm EX-FILING FEES 60442
5 forms-3_001.jpg GRAPHIC 7708
6 forms-3_002.jpg GRAPHIC 21771
  Complete submission text file 0001493152-24-024791.txt   485500
Mailing Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-280415 | Film No.: 241061368
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)